PURE BIOSCIENCE, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pure Bioscience, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q2 2024.
  • Pure Bioscience, Inc. Net Income (Loss) Attributable to Parent for the quarter ending July 31, 2024 was -$756K, a 26.7% increase year-over-year.
  • Pure Bioscience, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending July 31, 2024 was -$3.35M, a 15.4% increase year-over-year.
  • Pure Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$3.35M, a 15.4% increase from 2023.
  • Pure Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.96M, a 13.5% decline from 2022.
  • Pure Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.49M, a 50.5% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$3.35M -$756K +$276K +26.7% May 1, 2024 Jul 31, 2024 10-K 2024-10-29
Q1 2024 -$3.63M -$857K +$19K +2.17% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 -$3.65M -$1M +$58K +5.47% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 -$3.7M -$735K +$258K +26% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-14
Q2 2023 -$3.96M -$1.03M +$201K +16.3% May 1, 2023 Jul 31, 2023 10-K 2024-10-29
Q1 2023 -$4.16M -$876K -$116K -15.3% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 -$4.05M -$1.06M -$358K -51% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 -$3.69M -$993K -$197K -24.7% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-14
Q2 2022 -$3.49M -$1.23M -$500K -68.2% May 1, 2022 Jul 31, 2022 10-K 2023-10-30
Q1 2022 -$2.99M -$760K +$51K +6.29% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 -$3.04M -$702K -$107K -18% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 -$2.94M -$796K -$616K -342% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
Q2 2021 -$2.32M -$733K -$2.06M -155% May 1, 2021 Jul 31, 2021 10-K 2022-10-28
Q1 2021 -$264K -$811K -$1.28M -271% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $1.02M -$595K +$71K +10.7% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 $949K -$180K +$945K +84% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q2 2020 $4K $1.32M +$2.14M May 1, 2020 Jul 31, 2020 10-K 2021-10-28
Q1 2020 -$2.14M $473K +$2.35M Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-15
Q4 2019 -$4.48M -$666K +$630K +48.6% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-15
Q3 2019 -$5.11M -$1.13M +$1.44M +56.2% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-15
Q2 2019 -$6.55M -$819K +$565K +40.8% May 1, 2019 Jul 31, 2019 10-K 2020-10-08
Q1 2019 -$7.12M -$1.87M -$181K -10.7% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-11
Q4 2018 -$6.94M -$1.3M +$731K +36.1% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-12
Q3 2018 -$7.67M -$2.57M -$227K -9.71% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-13
Q2 2018 -$7.44M -$1.38M +$462K +25% May 1, 2018 Jul 31, 2018 10-K 2019-10-30
Q1 2018 -$7.9M -$1.69M +$46K +2.65% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-13
Q4 2017 -$7.95M -$2.03M -$1.09M -117% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-06
Q3 2017 -$6.86M -$2.34M -$596K -34.2% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-13
Q2 2017 -$6.26M -$1.85M -$1.17M -172% May 1, 2017 Jul 31, 2017 10-K 2018-10-25
Q1 2017 -$5.1M -$1.74M -$1.77M -5893% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-13
Q4 2016 -$3.33M -$936K +$9.97M +91.4% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-14
Q3 2016 -$13.3M -$1.74M +$1.08M +38.2% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-14
Q2 2016 -$14.4M -$679K +$1.19M +63.6% May 1, 2016 Jul 31, 2016 10-K 2017-10-26
Q1 2016 -$15.6M $30K +$2.12M Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-08
Q4 2015 -$17.7M -$10.9M -$9.17M -528% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-02
Q3 2015 -$8.51M -$2.82M -$886K -45.8% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-14
Q2 2015 -$7.63M -$1.87M +$809K +30.2% May 1, 2015 Jul 31, 2015 10-K 2016-10-27
Q1 2015 -$8.44M -$2.09M -$42K -2.05% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-09
Q4 2014 -$8.39M -$1.74M +$746K +30.1% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-09
Q3 2014 -$9.14M -$1.93M +$1.91M +49.7% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-10
Q2 2014 -$11.1M -$2.68M -$516K -23.9% May 1, 2014 Jul 31, 2014 10-K 2015-10-28
Q1 2014 -$10.5M -$2.05M -$515K -33.6% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-11
Q4 2013 -$10M -$2.48M -$658K -36.1% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-04
Q3 2013 -$9.36M -$3.84M -$1.69M -78.5% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-11
Q2 2013 -$7.67M -$2.16M +$348K +13.9% May 1, 2013 Jul 31, 2013 10-K 2014-10-28
Q1 2013 -$8.02M -$1.53M +$295K +16.1% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-10
Q4 2012 -$8.31M -$1.82M +$369K +16.8% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-13
Q3 2012 -$8.68M -$2.15M +$207K +8.77% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-12
Q2 2012 -$8.89M -$2.51M -$478K -23.6% May 1, 2012 Jul 31, 2012 10-K 2013-10-24
Q1 2012 -$8.41M -$1.83M -$11K -0.61% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 -$8.4M -$2.19M +$287K +11.6% Nov 1, 2011 Jan 31, 2012 10-Q 2013-02-25
Q3 2011 -$8.69M -$2.36M -$339K -16.8% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-11
Q2 2011 -$8.35M -$2.03M May 1, 2011 Jul 31, 2011 10-K 2012-10-29
Q1 2011 -$1.82M Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-13
Q4 2010 -$2.48M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q3 2010 -$2.02M Aug 1, 2010 Oct 31, 2010 10-Q/A 2011-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.